1 – 29 of 29
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma
(
- Contribution to journal › Article
-
Mark
Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma
(
- Contribution to journal › Article
-
Mark
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT
(
- Contribution to journal › Article
-
Mark
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
(
- Contribution to journal › Article
- 2017
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
-
Mark
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
(
- Contribution to journal › Article
- 2016
-
Mark
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.
(
- Contribution to journal › Article
-
Mark
Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.
(
- Contribution to journal › Article
- 2015
-
Mark
Molecular characterization of melanoma cases in denmark suspected of genetic predisposition.
(
- Contribution to journal › Article
-
Mark
Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma.
(
- Contribution to journal › Article
-
Mark
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions
(
- Contribution to journal › Article
-
Mark
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
(
- Contribution to journal › Article
-
Mark
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis
(
- Contribution to journal › Article
- 2014
-
Mark
Primary Melanoma Tumors from CDKN2A Mutation Carriers do not Belong to a Distinct Molecular Subclass.
(
- Contribution to journal › Article
-
Mark
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study
(
- Contribution to journal › Letter
-
Mark
The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length
(
- Contribution to journal › Article
- 2013
-
Mark
A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers
(
- Contribution to journal › Article
-
Mark
A variant in FTO shows association with melanoma risk not due to BMI
(
- Contribution to journal › Article
- 2012
-
Mark
Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk
(
- Contribution to journal › Letter
- 2011
-
Mark
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies three new melanoma susceptibility loci
(
- Contribution to journal › Article
- 2009
-
Mark
Genome-wide association study identifies three loci associated with melanoma risk
(
- Contribution to journal › Article
- 2008
-
Mark
Common sequence variants on 20q11.22 confer melanoma susceptibility
(
- Contribution to journal › Article
- 2007
-
Mark
Confirmation of a BRAF mutation-associated gene expression signature in melanoma
(
- Contribution to journal › Article
-
Mark
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
(
- Contribution to journal › Article
- 2006
-
Mark
Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN
(
- Contribution to journal › Article
-
Mark
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
(
- Contribution to journal › Article
- 2002
-
Mark
Genetic testing for melanoma
(
- Contribution to journal › Article